Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy

EAU Guidelines Office, Arnhem, The Netherlands. EAU guidelines: renal cell carcinoma. Uroweb. https://uroweb.org/guideline/renal-cell-carcinoma/#note_450. Abel, 2017, Cytoreductive nephrectomy for renal cell carcinoma with venous tumor thrombus, J Urol, 198, 281, 10.1016/j.juro.2017.03.011 Lenis, 2019, Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus—trends and effect on overall survival, Urol Oncol, 37, 577.e9, 10.1016/j.urolonc.2019.03.009 Slaton, 1997, Nephrectomy and vena caval thrombectomy in patients with metastatic renal cell carcinoma, Urology, 50, 673, 10.1016/S0090-4295(97)00329-4 Naitoh, 1999, Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy, J Urol, 162, 46, 10.1097/00005392-199907000-00012 Zisman, 2002, Renal cell carcinoma with tumor thrombus: is cytoreductive nephrectomy for advanced disease associated with an increased complication rate?, J Urol, 168, 962, 10.1016/S0022-5347(05)64552-1 Goetzl, 2004, A contemporary evaluation of cytoreductive nephrectomy with tumor thrombus: Morbidity and long-term survival, Urol Oncol, 22, 182, 10.1016/j.urolonc.2004.02.001 Manso, 2018, Renal cell carcinoma with venous thrombus: should surgery be offered when metastasis is present at diagnosis?, Urol Int, 101, 387, 10.1159/000493510 Qi, 2017, Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience, World J Surg Oncol, 15, 4, 10.1186/s12957-016-1066-3 SEER. About the SEER program. https://seer.cancer.gov/about/overview.html. Kovacs, 1997, The Heidelberg classification of renal cell tumours, J Pathol, 183, 131, 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G Moch, 2016, The 2016 WHO classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours, Eur Urol, 70, 93, 10.1016/j.eururo.2016.02.029 Nguyen, 2016, Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy, Urol Oncol, 34, 259.e1, 10.1016/j.urolonc.2016.01.005 Edge, 2010, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM, Ann Surg Oncol, 17, 1471, 10.1245/s10434-010-0985-4 RCT. R: a language and environment for statistical computing. 2017. https://wwwr-projectorg2017. Westesson, 2014, Surgical outcomes after cytoreductive nephrectomy with inferior vena cava thrombectomy, Urology, 84, 1414, 10.1016/j.urology.2014.05.078 Heng, 2014, Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium, Eur Urol, 66, 704, 10.1016/j.eururo.2014.05.034 Hanna, 2016, Survival analyses of patients with metastatic renal cancer treated with targeted therapy with or without cytoreductive nephrectomy: a National Cancer Data Base study, J Clin Oncol, 34, 3267, 10.1200/JCO.2016.66.7931 Palumbo, 2020, Contemporary cytoreductive nephrectomy provides survival benefit in clear-cell metastatic renal cell carcinoma, Clin Genitourin Cancer, 18, e730, 10.1016/j.clgc.2020.05.009 Li, 2021, Do Metastatic kidney cancer patients benefit from cytoreductive nephrectomy? A real-world retrospective study from the SEER database, Front Surg, 8, 716455, 10.3389/fsurg.2021.716455 Muselaers, 2021, Inferior vena cava involvement in renal cell carcinoma: if you fail to plan, you’re planning to fail, Minerva Urol Nephrol, 73, 854 Campi, 2021, Robotic surgery for renal cell carcinoma with inferior vena cava thrombosis: balancing feasibility and safety toward individualized decision-making, Minerva Urol Nephrol, 73, 544, 10.23736/S2724-6051.21.04606-1 Hoeh, 2022, Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy, Surg Oncol, 42, 101783, 10.1016/j.suronc.2022.101783 Nini, 2018, Perioperative and oncologic outcomes of nephrectomy and caval thrombectomy using extracorporeal circulation and deep hypothermic circulatory arrest for renal cell carcinoma invading the supradiaphragmatic inferior vena cava and/or right atrium, Eur Urol, 73, 793, 10.1016/j.eururo.2017.08.019 Ashrafi, 2020, Minimally invasive radical nephrectomy: a contemporary review, Transl Androl Urol, 9, 3112, 10.21037/tau-2019-suc-16 Méjean, 2018, Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma, N Engl J Med, 379, 417, 10.1056/NEJMoa1803675 Bex, 2019, Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial, JAMA Oncol, 5, 164, 10.1001/jamaoncol.2018.5543 Rini, 2019, Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma, N Engl J Med, 380, 1116, 10.1056/NEJMoa1816714 Choueiri, 2021, Nivolumab plus cabozantinib versus sunitinib for advanced renal-cell carcinoma, N Engl J Med, 384, 829, 10.1056/NEJMoa2026982 Motzer, 2021, Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma, N Engl J Med, 384, 1289, 10.1056/NEJMoa2035716 Motzer, 2018, Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma, N Engl J Med, 378, 1277, 10.1056/NEJMoa1712126 Benamran, 2022, Treatment options for de novo metastatic clear-cell renal cell carcinoma: current recommendations and future insights, Eur Urol Oncol, 5, 125, 10.1016/j.euo.2021.08.003 Roussel, 2021, Three years after CARMENA: what have we learned?, Eur Urol, 80, 425, 10.1016/j.eururo.2021.07.007 Meza, 2022, Cytoreductive nephrectomy in 2021: obsolete, Eur Urol Open Sci, 36, 44, 10.1016/j.euros.2021.09.021 Capitanio, 2022, Cytoreductive nephrectomy in 2021: obsolete but necessary, Eur Urol Open Sci, 36, 41, 10.1016/j.euros.2021.12.004 Marchioni, 2019, Survival after cytoreductive nephrectomy in metastatic non-clear cell renal cell carcinoma patients: a population-based study, Eur Urol Focus, 5, 488, 10.1016/j.euf.2017.11.012